To account for the inter-patient matrisome heterogeneity, we included 157 IDH wild type (WT) GBM samples from 151 patients with varying coverages for genomic, transcriptomic, proteomic, and clinical data from the TCGA GBM dataset12 (Supplementary Table 2). The gene discussed is IDH1; the disease is glioblastoma.